HPV Status and second primary tumours in Oropharyngeal Squamous Cell Carcinoma

Journal of Otolaryngology - Head and Neck Surgery

Volumn 42, Issue MAY, 2013, Pages

  Xu, Caroline C ^a   Biron, Vincent L ^a   Puttagunta, Lakshmi ^a   Seikaly, Hadi ^a  

^a UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

Author keywords

HPV; Oropharynx; P16; Panendoscopy; Second primary tumours

Indexed keywords

PROTEIN P16; P16 PROTEIN, HUMAN; TUMOR PROTEIN;

ADULT; ARTICLE; CANADA; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OROPHARYNX CARCINOMA; OROPHARYNX SQUAMOUS CELL CARCINOMA; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SECOND CANCER; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY; AGED; ALGORITHM; HEAD AND NECK TUMOR; INCIDENCE; METABOLISM; OROPHARYNX TUMOR; VIROLOGY;

AGED; ALGORITHMS; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASMS, SECOND PRIMARY; OROPHARYNGEAL NEOPLASMS; RETROSPECTIVE STUDIES; TISSUE ARRAY ANALYSIS;

EID: 84895438045     PISSN: 19160216     EISSN: None     Source Type: Journal    
DOI: 10.1186/1916-0216-42-36     Document Type: Article

References (23)

1. Johnson-Obaseki S., McDonald JT, Corsten M, Rourke R: Head and Neck Cancer in Canada: Trends 1992 to 2007. Otolaryngol Head Neck Surg 2012, 147(1):74-78. Epub Feb 10.
2. Ryerson AB, Peters ES, Coughlin S.S., Chen VW, Gillison ML, Reichman ME, Wu X, Chaturvedi A.K., Kawaoka K: Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003. Cancer 2008 Nov 15, 113(10 Suppl):2901-2909.
3. Heath S, Willis V, Allan K., Purdie K, Harwood C, Shields P., Simcock R, Williams T, Gilbert DC: Clinically significant human papilloma virus in squamous cell carcinoma of the head and neck in UK practice. Clin Oncol (R Coll Radiol) 2012, 24(1):e18-e23. Epub 2011 Jul 14.
4. van Monsjou H.S., Balm AJ, van den Brekel MM, Wreesmann VB: Oropharyngeal squamous cell carcinoma: a unique disease on the rise? Oral Oncol 2010, 46(11):780-785. Review.
5. McKaig RG, Baric RS, Olshan AF: Human papitlonia - virus and head and neck cancer: epidemiology and molecular biology. Head Neck 1998, 20:250-265.
6. Van Houten V.M., Snijders PJ, Van den Brckel MW, Kummer JA, et al.: Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int J Cancer 2001, 93:232-235.
7. Fouret P, Monceaux G, Temam S., et al.: Human papillomavirus in head and neck squamous cell carcinomas in nonsmokers. Arch Otolaryngol Head Neck Surg 1997, 123:513-516.
8. Biron VL, Côté DW, Seikaly H: Oropharyngeal squamous cell carcinoma and human papillomavirus-associated cancers in women: epidemiologic evaluation of association. J Otolaryngol Head Neck Surg 2011 Feb, 40(Suppl. 1):S65-S69.
9. Gillison ML, D'Souza G, Westra W, et al.: Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 2008, 100:407-420.
10. Ang KK, Harris J, Wheeler R., et al.: Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010, 363:24-35.
11. Leemans CR, Braakhuis BJM, Brakenhoff RH: The molecular biology of head and neck cancer. Nat Rev Cancer 2011, 11:9-22.
12. Levine B, Nielsen EW: The justifications and controversies of panendoscopy - A review. Ear, Nose and Throat J 1992, 71(8):335-343.
13. Xu GX, Guan DJ, He ZY: 18FDG-PET/CT for detecting distant metastases and second primary cancers in patients with head and neck cancer: a metanalysis. Oral Oncology 2011, 47(7):560-565.
14. D'Souza G., Kreimer AR, Viscidi R, et al.: Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007, 356:1944-1956.
15. Licitra L, Perrone F, Bossi P., et al.: High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol 2006, 24:5630-5636.
16. Morris LGT, Sikora AG, Patel S.G., et al.: Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus - associated oropharygneal cancer. J of Clin Onc 2011, 29(6):739-746.
17. Kononen J, Bubendorf L, Kallioniemi A., et al.: Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998, 4:844-847.
18. Prabhu PR, Jayalekshmi D, Pillai MR: Lung cancer and human papilloma viruses (HPVs): examining the molecular evidence. J Oncol 2012, 750270. Epub 2012 Jan 26.
19. Benninger MS, Shariff A, Blazoff K: Symptom-directed selective endoscopy: long-term efficacy. Arch Otolaryngol Head Neck Surg 2001, 127(7):770-3.
20. Kurien G, Hu J, Harris J., Seikaly H: Cost-effectiveness of positron emission tomography/computed tomography in the management of advanced head and neck cancer. J Otolaryngol Head Neck Surg 2011 Dec, 40(6):468-72.
21. Goyal P, Hsu JM, Kellman RM: Effect of 18F-fluorodeoxyglucose positron emission tomography on the management of patients with head and neck squamous cell carcinoma. J Otolaryngol Head Neck Surg 2008, 37:694-9.
22. Smith EM, Rubenstein LM, Haugen T.H., et al.: Tobacco and alcohol use increases the risk of both HPV-associated and HPV-independent head and neck cancers. Cancer Causes Control 2010, 21:1369-78.
23. Pannone G, Rodolico V, Santoro A., et al.: Evaluation of combined triple method to detecet causative HPV in oral and oropharyngeal squamous cell carcinomas: p16 immunohistochemistry, consensus PCR HPV-DNA, and in situ hybridization. Infect Agent Cancer 2012, 7(1):4